In the article titled “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer” [1], the authors wish to provide the following acknowledgement that was omitted in error:
This work was financially supported by the Natural Science Foundation of Guangdong Province (2021A1515011050) and Science and Technology Projects in Guangzhou (202102080100).
Additionally, the order of authors was listed incorrectly, and the correct order is as shown above.
Contributor Information
Guobing Liu, Email: guobingliu6081@sina.com.
Xuefeng Wang, Email: douwangxuefeng@163.com.
References
- 1.Li G., Wang X., Liu G. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer. BioMed Research International . 2021;2021 doi: 10.1155/2021/5512340.5512340 [DOI] [PMC free article] [PubMed] [Google Scholar]